Clinical Trial Update: Effect of Two Different Doses of Neostigmine on the Gastric Residual Volume and Aspiration in Critically Ill Patients

View source ↗

Summary

A completed clinical trial comparing two doses of neostigmine to assess effects on gastric residual volume and aspiration risk in critically ill patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Neostigmine (neostigmine)

Snippet

Sponsor: Zulekha Hospitals | Conditions: Gastric Reflux | Status: COMPLETED